270 related articles for article (PubMed ID: 25363551)
1. Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters.
Wargon V; Riggio M; Giulianelli S; Sequeira GR; Rojas P; May M; Polo ML; Gorostiaga MA; Jacobsen B; Molinolo A; Novaro V; Lanari C
Int J Cancer; 2015 Jun; 136(11):2680-92. PubMed ID: 25363551
[TBL] [Abstract][Full Text] [Related]
2. Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.
Rojas PA; May M; Sequeira GR; Elia A; Alvarez M; Martínez P; Gonzalez P; Hewitt S; He X; Perou CM; Molinolo A; Gibbons L; Abba MC; Gass H; Lanari C
J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376177
[TBL] [Abstract][Full Text] [Related]
3. Progesterone receptor isoform ratio dictates antiprogestin/progestin effects on breast cancer growth and metastases: A role for NDRG1.
Abascal MF; Elia A; Alvarez M; Pataccini G; Sequeira G; Riggio M; Figueroa V; Lamb CA; Rojas PA; Spengler E; Martínez-Vazquez P; Burruchaga J; Liguori M; Sahores A; Wargon V; Molinolo A; Hewitt S; Lombes M; Sartorius C; Vanzulli SI; Giulianelli S; Lanari C
Int J Cancer; 2022 May; 150(9):1481-1496. PubMed ID: 34935137
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer.
Sequeira G; Vanzulli SI; Rojas P; Lamb C; Colombo L; May M; Molinolo A; Lanari C
Oncotarget; 2014 May; 5(10):3246-60. PubMed ID: 24912774
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas.
Wargon V; Fernandez SV; Goin M; Giulianelli S; Russo J; Lanari C
Breast Cancer Res Treat; 2011 Apr; 126(2):319-32. PubMed ID: 20440553
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.
Giulianelli S; Vaqué JP; Soldati R; Wargon V; Vanzulli SI; Martins R; Zeitlin E; Molinolo AA; Helguero LA; Lamb CA; Gutkind JS; Lanari C
Cancer Res; 2012 May; 72(9):2416-27. PubMed ID: 22396492
[TBL] [Abstract][Full Text] [Related]
7. [The role of estrogen receptor alpha in breast cancer cell proliferation mediated by progestins].
Giulianelli S; Vaqué JP; Wargon V; Soldati R; Vanzulli SI; Martins R; Zeitlin E; Helguero L; Lamb C; Molinolo AA; Gutkind JS; Lanari C
Medicina (B Aires); 2012; 72(4):315-20. PubMed ID: 22892083
[TBL] [Abstract][Full Text] [Related]
8. Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B.
Wu J; Richer J; Horwitz KB; Hyder SM
Cancer Res; 2004 Mar; 64(6):2238-44. PubMed ID: 15026368
[TBL] [Abstract][Full Text] [Related]
9. Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor.
McGowan EM; Russell AJ; Boonyaratanakornkit V; Saunders DN; Lehrbach GM; Sergio CM; Musgrove EA; Edwards DP; Sutherland RL
Cancer Res; 2007 Sep; 67(18):8942-51. PubMed ID: 17875737
[TBL] [Abstract][Full Text] [Related]
10. Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressor.
Karmakar S; Gao T; Pace MC; Oesterreich S; Smith CL
Mol Endocrinol; 2010 Jun; 24(6):1187-202. PubMed ID: 20392877
[TBL] [Abstract][Full Text] [Related]
11. Progesterone Receptor Isoforms A and B in Pancreatic Neuroendocrine Tumor.
Yazdani S; Kasajima A; Ogata H; Felizola SJ; Nakamura Y; Onodera Y; Watanabe M; Motoi F; Unno M; Sasano H
Neuroendocrinology; 2015; 101(4):309-20. PubMed ID: 25791399
[TBL] [Abstract][Full Text] [Related]
12. p38 and p42/44 MAPKs differentially regulate progesterone receptor A and B isoform stabilization.
Khan JA; Amazit L; Bellance C; Guiochon-Mantel A; Lombès M; Loosfelt H
Mol Endocrinol; 2011 Oct; 25(10):1710-24. PubMed ID: 21816898
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of breast cancer-associated genes by progesterone receptor isoforms PRA and PRB in a new bi-inducible breast cancer cell line.
Khan JA; Bellance C; Guiochon-Mantel A; Lombès M; Loosfelt H
PLoS One; 2012; 7(9):e45993. PubMed ID: 23029355
[TBL] [Abstract][Full Text] [Related]
14. Effect of overexpression of progesterone receptor A on endogenous progestin-sensitive endpoints in breast cancer cells.
McGowan EM; Clarke CL
Mol Endocrinol; 1999 Oct; 13(10):1657-71. PubMed ID: 10517668
[TBL] [Abstract][Full Text] [Related]
15. New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP.
Sartorius CA; Groshong SD; Miller LA; Powell RL; Tung L; Takimoto GS; Horwitz KB
Cancer Res; 1994 Jul; 54(14):3868-77. PubMed ID: 8033109
[TBL] [Abstract][Full Text] [Related]
16. Increased High Molecular Weight FGF2 in Endocrine-Resistant Breast Cancer.
Sahores A; Figueroa V; May M; Liguori M; Rubstein A; Fuentes C; Jacobsen BM; Elía A; Rojas P; Sequeira GR; Álvarez MM; González P; Gass H; Hewitt S; Molinolo A; Lanari C; Lamb CA
Horm Cancer; 2018 Oct; 9(5):338-348. PubMed ID: 29956066
[TBL] [Abstract][Full Text] [Related]
17. Reversal of antiprogestin resistance and progesterone receptor isoform ratio in acquired resistant mammary carcinomas.
Wargon V; Helguero LA; Bolado J; Rojas P; Novaro V; Molinolo A; Lanari C
Breast Cancer Res Treat; 2009 Aug; 116(3):449-60. PubMed ID: 18677559
[TBL] [Abstract][Full Text] [Related]
18. Differential quantitative proteomics reveals key proteins related to phenotypic changes of breast cancer cells expressing progesterone receptor A.
Pateetin P; Pisitkun T; McGowan E; Boonyaratanakornkit V
J Steroid Biochem Mol Biol; 2020 Apr; 198():105560. PubMed ID: 31809870
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
[TBL] [Abstract][Full Text] [Related]
20. Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells.
Labriola L; Salatino M; Proietti CJ; Pecci A; Coso OA; Kornblihtt AR; Charreau EH; Elizalde PV
Mol Cell Biol; 2003 Feb; 23(3):1095-111. PubMed ID: 12529413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
